Proteome Sciences and King's Health Partners team up to validate Alzheimer's biomarkers
This article was originally published in Clinica
Executive Summary
By the end of this month, researchers at King's Health Partners, a UK academic health sciences centre, and UK diagnostics specialist Proteome Sciences will start analysing data from a 1,000-patient study of protein biomarkers in Alzheimer's disease.